000 02436 a2200709 4500
005 20250518003949.0
264 0 _c20200504
008 202005s 0 0 eng d
022 _a1755-3245
024 7 _a10.1093/cvr/cvy252
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKrishnan, Shalini M
245 0 0 _aPharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
_h[electronic resource]
260 _bCardiovascular research
_c03 2019
300 _a776-787 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAlbuminuria
_xetiology
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents
_xpharmacology
650 0 4 _aAntihypertensive Agents
_xpharmacology
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aChemotaxis, Leukocyte
_xdrug effects
650 0 4 _aCollagen
_xmetabolism
650 0 4 _aDesoxycorticosterone Acetate
650 0 4 _aDisease Models, Animal
650 0 4 _aFibrosis
650 0 4 _aFurans
_xpharmacology
650 0 4 _aHeterocyclic Compounds, 4 or More Rings
650 0 4 _aHypertension
_xetiology
650 0 4 _aIndenes
650 0 4 _aInflammation Mediators
_xmetabolism
650 0 4 _aKidney
_xdrug effects
650 0 4 _aMacrophages
_xdrug effects
650 0 4 _aMale
650 0 4 _aMice, Inbred C57BL
650 0 4 _aNLR Family, Pyrin Domain-Containing 3 Protein
_xantagonists & inhibitors
650 0 4 _aNephrectomy
650 0 4 _aSignal Transduction
650 0 4 _aSodium Chloride, Dietary
650 0 4 _aSulfonamides
_xpharmacology
650 0 4 _aSulfones
650 0 4 _aT-Lymphocyte Subsets
_xdrug effects
700 1 _aLing, Yeong H
700 1 _aHuuskes, Brooke M
700 1 _aFerens, Dorota M
700 1 _aSaini, Narbada
700 1 _aChan, Christopher T
700 1 _aDiep, Henry
700 1 _aKett, Michelle M
700 1 _aSamuel, Chrishan S
700 1 _aKemp-Harper, Barbara K
700 1 _aRobertson, Avril A B
700 1 _aCooper, Matthew A
700 1 _aPeter, Karlheinz
700 1 _aLatz, Eicke
700 1 _aMansell, Ashley S
700 1 _aSobey, Christopher G
700 1 _aDrummond, Grant R
700 1 _aVinh, Antony
773 0 _tCardiovascular research
_gvol. 115
_gno. 4
_gp. 776-787
856 4 0 _uhttps://doi.org/10.1093/cvr/cvy252
_zAvailable from publisher's website
999 _c28974624
_d28974624